Viewing Study NCT07214532


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2025-12-25 @ 7:24 PM
Study NCT ID: NCT07214532
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-23
First Post: 2025-09-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Sponsor: Natera, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module